Skip to main content
logo
Botanix Pharmaceuticals Limited (ASX:BOT)
Australia flag Australia · Delayed Price · Currency is AUD
0.1100
0.00 (0.00%)
Jan 30, 2026, 11:02 AM AEST

Botanix Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Botanix Pharmaceuticals had annual revenue of 5.79M AUD with 179.74% growth. Botanix Pharmaceuticals had revenue of 5.41M in the half year ending June 30, 2025, with 9,028.10% growth.

Revenue
5.79M
Revenue Growth
+179.74%
P/S Ratio
37.43
Revenue / Employee
526.29K
Employees
11
Market Cap
216.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.79M3.72M179.74%
Jun 30, 20242.07M-1.70M-45.14%
Jun 30, 20233.77M1.02M36.94%
Jun 30, 20222.75M-4.13M-60.00%
Jun 30, 20216.89M-686.66K-9.07%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Orthocell7.55M
Recce Pharmaceuticals7.51M
Racura Oncology6.04M
Starpharma Holdings5.85M
Dimerix5.59M
Actinogen Medical5.49M
Imugene4.40M
Arovella Therapeutics3.44M
Revenue Rankings

Botanix Pharmaceuticals News

More News